N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide

C13H22N4O3 — CID 63297725

IUPACN-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide
SMILESCN(CC(=O)NC(=O)CN1CCCC1=O)C1CCNC1
InChIInChI=1S/C13H22N4O3/c1-16(10-4-5-14-7-10)8-11(18)15-12(19)9-17-6-2-3-13(17)20/h10,14H,2-9H2,1H3,(H,15,18,19)
InChIKeyBUSHOLLBBVWGRT-UHFFFAOYSA-N
MW282.34 g/mol
LogP-1.45
Rot. Bonds5

About N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide

N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide (PubChem CID 63297725) has the molecular formula C13H22N4O3 and a molecular weight of 282.34 g/mol. Its IUPAC name is N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide.

Molecular Properties

Compound NameN-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide
PubChem CID63297725
Molecular FormulaC13H22N4O3
Molecular Weight282.34 g/mol
Exact Mass282.17
IUPAC NameN-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide
SMILESCN(CC(=O)NC(=O)CN1CCCC1=O)C1CCNC1
InChIInChI=1S/C13H22N4O3/c1-16(10-4-5-14-7-10)8-11(18)15-12(19)9-17-6-2-3-13(17)20/h10,14H,2-9H2,1H3,(H,15,18,19)
InChIKeyBUSHOLLBBVWGRT-UHFFFAOYSA-N
XLogP-1.45
TPSA81.75 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500282.34
LogP ≤ 5-1.45
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-[methyl(piperidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide
CID 63643556
2-(2-oxopyrrolidin-1-yl)-N-propyl-N-pyrrolidin-3-ylacetamide
CID 60806352
2-[(2R)-2-methylpiperazin-1-yl]-N-[2-(2-oxopyrrolidin-1-yl)acetyl]acetamide
CID 82756124
2-(2-oxoazepan-1-yl)-N-pyrrolidin-3-ylacetamide
CID 119451455
2-(2-oxoazepan-1-yl)-N-propyl-N-pyrrolidin-3-ylacetamide
CID 119531180
2-(2-oxopiperidin-1-yl)-N-piperidin-3-ylacetamide
CID 119427764
N-[2-[ethyl(2-hydroxyethyl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide
CID 60686109
N-cyclohexyl-2-[methyl(pyrrolidin-3-yl)amino]acetamide;hydrochloride
CID 119922828
N-(4-methylphenyl)-2-[methyl(pyrrolidin-3-yl)amino]acetamide;hydrochloride
CID 119922897
2-[methyl(pyrrolidin-3-yl)amino]-1-piperidin-1-ylethanone
CID 63301733
N-cyclohexyl-N-methyl-2-(2-oxoazepan-1-yl)acetamide
CID 51075621
2-[(3R)-3-hydroxypyrrolidin-1-yl]-N-[2-(2-oxopyrrolidin-1-yl)acetyl]acetamide
CID 79030579

Frequently Asked Questions

What is the IUPAC name of N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide?
The IUPAC name of N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide (CID 63297725) is N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide.
What is the SMILES notation for N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide?
The canonical SMILES for N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide is CN(CC(=O)NC(=O)CN1CCCC1=O)C1CCNC1.
What is the InChIKey of N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide?
The InChIKey is BUSHOLLBBVWGRT-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H22N4O3/c1-16(10-4-5-14-7-10)8-11(18)15-12(19)9-17-6-2-3-13(17)20/h10,14H,2-9H2,1H3,(H,15,18,19).
What are the key properties of N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide?
N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide has a molecular weight of 282.34 g/mol, XLogP of -1.45, 5 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[methyl(pyrrolidin-3-yl)amino]acetyl]-2-(2-oxopyrrolidin-1-yl)acetamide is sourced from PubChem (CID 63297725), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).